Empirical use of vancomycin in neonates. Risks greater than benefits
Víctor Garay Gutiérrez
Abstract:
Vancomicina es un antibiótico prescrito en unidades de cuidado intensivo neonatal con frecuencia. Su uso empírico ha sido evaluado comparándolo con sus riesgos. Siendo los riesgos mayores a los beneficios es importante reservar su uso para infecciones resistentes documentadas en neonatos e infecciones nosocomiales severas.
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.